Dopaminergic antiparkinsonism agents

GS WXG Pill - brown oval, 13mm

Generic Name: ropinirole

Pill with imprint GS WXG is Brown, Oval and has been identified as Requip XL 4 mg. It is supplied by GlaxoSmithKline.

Requip XL is used in the treatment of Periodic Limb Movement Disorder; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip XL 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Requip xl (Ropinirole (oral) [ roe-pin-i-role ])-GS WXG-4 mg-Brown-Oval
Requip xl (Ropinirole (oral) [ roe-pin-i-role ])-GS WXG-4 mg-Brown-Oval
Requip xl (Ropinirole (oral) [ roe-pin-i-role ])-GS WXG-4 mg-Brown-Oval

Requip xl
Generic Name: ropinirole (oral) [ roe-pin-i-role ]
Imprint: GS WXG
Strength: 4 mg
Color: Brown
Size: 13.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00007-4887 (Discontinued)
Inactive Ingredients: Silicon dioxide, Hydrogenated castor oil, Hypromelloses, Lactose monohydrate, Magnesium stearate, Maltodextrin, Mannitol, Povidone, Hypromellose 2910 (6 mPa.s), Titanium dioxide, FD&C Yellow No. 6, Polyethylene glycol 400, FD&C Blue No. 2,
Latest News
Related Drugs